The Department of Medicine is excited to announce that Richard D. Wainford, PhD, FAHA, will join the Division of Cardiology as the R. Bruce Logue Chair of Cardiology and Acting Professor of Medicine on June 1, 2023. Dr. Wainford comes to Emory from Boston University School of Medicine’s Department of Pharmacology & Experimental Therapeutics and the Whitaker Cardiovascular Institute where he serves as an Associate Professor of Pharmacology and MedicineAdjunct Associate Professor at the School of Biological Sciences, Monash University in Melbourne, Australia.
The overarching goal of Dr. Wainford’s translational research program is to drive the development of clinically relevant mechanism-based approaches for the detection, prevention, and treatment of hypertension, the SSBP and hypertension-driven cognitive impairment across the lifespan. Hypertension, the prevalence of which increases with age, affects approximately 1 in 2 U.S. adults, is the leading global non-communicable cause of mortality, and is an independent modifiable risk factor for cognitive impairment. The salt sensitivity of blood pressure, which is not routinely assessed, affects ~50% of hypertensive and ~25% of normotensive adults and profoundly increases the risk of hypertension. Highlighting the public health significance of hypertension only ~48% of U.S. hypertensive patients receiving treatment have controlled hypertension. Dr. Wainford’s research program is designed to provide novel insights into the integrated role(s) of the brain, the kidney, and aging in hypertension and the impact of hypertension on vascular cognitive impairment.
Dr. Wainford has received many awards, including the American Physiology Society 2014 Arthur C Guyton Award for Excellence in Integrative Physiology and Medicine, the 2013 American Physiology Society Shih-Chun Wang Young Investigator Award, the American Physiological Society Central Nervous System Sections 2013 New Investigator Award, the 2012 Dean Franklin Young Investigator Award, and the 2013 Harry Goldblatt Awardee by the American Heart Association Hypertension Council.
Dr. Wainford obtained his bachelor’s degree in Zoology from the University of Wales, Cardiff in 1999 and undertook his graduate training in the Laboratory of Molecular Pharmacology and Toxicology in the Department of Medicine and Therapeutics at the University of Aberdeen School of Medicine under the guidance of Professor Hawksworth, earning a PhD in Molecular Pharmacology in 2004. He then completed a two-year post-doctoral fellowship in the Department of Pharmacology at the Louisiana State University Health Sciences Center in New Orleans in Cardiovascular & Renal Pharmacology under the mentorship of Dr. Daniel Kapusta. Dr. Wainford then became an Instructor of Pharmacology in 2008, remaining in the laboratory of Dr. Kapusta until his promotion to the rank of Assistant Professor in 2010. Dr. Wainford joined the Department of Pharmacology & Experimental Therapeutics at Boston University’s School of Medicine and the Whitaker Cardiovascular Institute in 2011 as an Assistant Professor.
Dr. Wainford’s research has appeared in publications such as the Journal of the Federation of American Societies for Experimental Biology, Hypertension, the British Journal of Pharmacology, the Journal of Hypertension, and the American Journal of Physiology Regulatory, Integrative, and Comparative Physiology. He served as Chair of the 2020-2022 American Heart Association Clinical Fellowship Review Panel and is a permanent member of the Department of Veterans Affairs Rehabilitation Research and Development Scientific Merit Review Board Chronic Medical Conditions and Aging panel and the NIH CSR Integrated Vascular Physiology and Pathophysiology Study Section.
Please join us in welcoming Dr. Wainford to Emory and the Department of Medicine.
Be the first to comment on "Richard D. Wainford, PhD, FAHA, to join Emory as the R. Bruce Logue Chair of Cardiology"